According to Biomerica's latest financial reports and stock price the company's current Operating Margin is -74.05%. At the end of 2022 the company had an Operating Margin of -23.88%.
Year | Operating Margin | Change |
---|---|---|
2022 | -23.88% | -73.37% |
2021 | -89.67% | 157.4% |
2020 | -34.84% | -23.51% |
2019 | -45.55% | 76.73% |
2018 | -25.77% | 64.33% |
2017 | -15.68% | 1.29% |
2016 | -15.48% | 18.86% |
2015 | -13.03% | 56.48% |
2014 | -8.33% | -202.69% |
2013 | 8.11% | -19.84% |
2012 | 10.11% | 199.81% |
2011 | 3.37% | -151.55% |
2010 | -6.54% | -209.58% |
2009 | 5.97% | -42.25% |
2008 | 10.34% | 14.15% |
2007 | 9.06% | -770.46% |
2006 | -1.35% | -46.62% |
2005 | -2.53% | -26.58% |
2004 | -3.45% | 48.84% |
2003 | -2.32% | -57.2% |
2002 | -5.41% | -29.21% |
2001 | -7.65% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Align Technology
ALGN | 16.04% | -121.66% | ๐บ๐ธ USA |
Dentsply Sirona
XRAY | -26.89% | -63.69% | ๐บ๐ธ USA |
Biolase
BIOL | -41.06% | -44.55% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.